MEI Pharma's Total Assets for the quarter that ended in Sep. 2024 was $27.75 Mil.
During the past 12 months, MEI Pharma's average Total Assets Growth Rate was -95.60% per year.
During the past 3 years, the average Total Assets Growth Rate was -47.30% per year.
During the past 5 years, the average Total Assets Growth Rate was -15.00% per year.
During the past 10 years, the average Total Assets Growth Rate was 35.90% per year.
During the past 13 years, MEI Pharma's highest 3-Year average Total Assets Growth Rate was 133.10%. The lowest was -47.30%. And the median was 36.30%.
Total Assets is connected with ROA %. MEI Pharma's annualizedROA % for the quarter that ended in Sep. 2024 was -92.67%. Total Assets is also linked to Revenue through Asset Turnover. MEI Pharma's Asset Turnover for the quarter that ended in Sep. 2024 was 0.00.
MEI Pharma Total Assets Historical Data
The historical data trend for MEI Pharma's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
MEI Pharma's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Sep. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
MEI Pharma's Asset Turnover for the quarter that ended in Sep. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
MEI Pharma Total Assets Related Terms
Thank you for viewing the detailed overview of MEI Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEIP has been successfully added to your 